tiprankstipranks
Trending News
More News >
RemeGen Co. Ltd. Class H (HK:9995)
:9995

Compare RemeGen Co. Ltd. Class H (9995) vs. Competitors

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RemeGen Co. Ltd. Class H
HK$84.20
HK$58.04B
-44.61
534.04%
4 Buy
2 Hold
0 Sell
Moderate Buy
Genscript Biotech
HK$14.33
HK$27.95B
20.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Zai Lab Ltd
HK$22.18
HK$14.67B
-8.64
-37.18%
6 Buy
2 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$21.38
HK$36.44B
-20.84
94.36%
0 Buy
1 Hold
0 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$11.69
HK$30.34B
30.28
70.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.14B
34.99
241.89%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9995
RemeGen Co. Ltd. Class H
84.20
70.92
534.04%
HK:1548
Genscript Biotech
12.85
2.17
20.32%
HK:9688
Zai Lab Ltd
13.13
-7.72
-37.03%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
21.38
10.38
94.36%
HK:2096
Simcere Pharmaceutical Group Limited
11.69
4.88
71.66%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.30
40.32
237.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts